Page last updated: 2024-11-02

pioglitazone and Allergic Neuritis, Experimental

pioglitazone has been researched along with Allergic Neuritis, Experimental in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"Pioglitazone was given once daily (10 mg/kg) by oral gavage feeding from day 1-24 (suppressive group) and day 11-24 (therapeutic group)."1.38Pioglitazone, PPARĪ³ agonist, attenuates experimental autoimmune neuritis. ( Hurbungs, A; Li, J; Ramkalawan, H; Tian, FF; Wang, YZ; Xiao, B; Yang, H; Yang, YF; Zhang, W; Zhou, WB, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramkalawan, H1
Wang, YZ1
Hurbungs, A1
Yang, YF1
Tian, FF1
Zhou, WB1
Li, J1
Yang, H1
Xiao, B1
Zhang, W1

Other Studies

1 other study available for pioglitazone and Allergic Neuritis, Experimental

ArticleYear
Pioglitazone, PPARĪ³ agonist, attenuates experimental autoimmune neuritis.
    Inflammation, 2012, Volume: 35, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Interferon-gamma; Interleukin-4; Male; Neuritis, A

2012